Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease

被引:221
作者
Rugtveit, J
Nilsen, EM
Bakka, A
Carlsen, H
Brandtzaeg, P
Scott, H
机构
[1] UNIV OSLO,NATL HOSP,RIKSHOSP,DEPT SURG B,OSLO,NORWAY
[2] UNIV OSLO,NATL HOSP,RIKSHOSP,INST SURG RES,OSLO,NORWAY
关键词
D O I
10.1016/S0016-5085(97)70030-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Most macrophages in the normal intestinal mucosa have a mature phenotype, in inflammatory bowel disease (IBD), a monocyte-like subset (CD14(+)L1(+)) accumulates, The aim of this study was to characterize its potential with regard to cytokines, Methods: Lamina propria mononuclear cells were adherence-separated, with or without depletion of CD14(+) cells, and production of cytokines was investigated by bioassay, enzyme-linked immunosorbent assay, or immunocytochemistry, Results: Tumor necrosis factor-alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), and IL-1 receptor antagonist were found mainly in cells positive for myelomonocytic L1. In undepleted IBD cultures, TNF-alpha, IL-1 alpha and beta, and IL-10 were markedly up-regulated by pokeweed mitogen stimulation; IL-1 alpha and beta and IL-10 were also up-regulated by stimulation of interferon gamma and lipopolysaccharide in combination, The latter stimulation had no effect on normal control or CD14-depleted IBD cultures, Indomethacin caused a marked increase of TNF-alpha, particularly in undepleted IBD cultures, whereas IL-10 and IL-4 decreased TNF-alpha and IL-1 beta in both CD14(+) and CD14 macrophages. Conclusions: In IBD mucosa, macrophages with a monocyte-like phenotype are primed for production of TNF-alpha; IL-1 alpha and beta may therefore have significant pathogenic importance. However, this CD14(+) subset, as well as the mucosal resident macrophages, have preserved responsiveness to several down-regulatory factors such as the macrophage deactivators IL-10 and IL-4.
引用
收藏
页码:1493 / 1505
页数:13
相关论文
共 79 条
[1]
STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]
ALLEN JB, 1993, J IMMUNOL, V151, P4344
[3]
ALLISON MC, 1991, CLIN EXP IMMUNOL, V85, P504
[4]
MACROPHAGE HETEROGENEITY IN NORMAL COLONIC MUCOSA AND IN INFLAMMATORY BOWEL-DISEASE [J].
ALLISON, MC ;
CORNWALL, S ;
POULTER, LW ;
DHILLON, AP ;
POUNDER, RE .
GUT, 1988, 29 (11) :1531-1538
[5]
HUMAN INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR-ALPHA PRODUCTION STUDIED AT A SINGLE-CELL LEVEL [J].
ANDERSSON, U ;
MATSUDA, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (06) :1157-1160
[6]
ANDUS T, 1994, GASTROENTEROLOGY, V106, pA645
[7]
BANNAI H, 1994, GASTROENTEROLOGY, V106, pA649
[8]
RECEPTORS FOR COLD-INSOLUBLE GLOBULIN (PLASMA FIBRONECTIN) ON HUMAN-MONOCYTES [J].
BEVILACQUA, MP ;
AMRANI, D ;
MOSESSON, MW ;
BIANCO, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (01) :42-60
[9]
MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[10]
THE LEUKOCYTE PROTEIN-L1 (CALPROTECTIN) - USEFULNESS AS AN IMMUNOHISTOCHEMICAL MARKER ANTIGEN AND PUTATIVE BIOLOGICAL FUNCTION [J].
BRANDTZAEG, P ;
DALE, I ;
GABRIELSEN, TO .
HISTOPATHOLOGY, 1992, 21 (02) :191-196